Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.00 (0.00%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Convertible Loan Note Offer

18 Jul 2006 15:48

Azure Holdings PLC18 July 2006 Azure Holdings plc (the "Company") Convertible Loan Note Offer The Company announces that it has today issued a letter to holders of ordinaryshares of 1p each in the Company ("Ordinary Shares"), on the share register ofthe Company on 17 July 2006, offering them the opportunity to participate in thesubscription of up to £1,200,000 nominal unsecured convertible loan stock 2008("Loan Stock"). The Loan Stock is being offered following discussions regarding a proposedacquisition by the Company ("Acquisition"). The proposed target for theAcquisition is ValiRX Limited ("ValiRX"), a biopharmaceutical developmentcompany. Discussions with ValiRX are progressing and the directors of theCompany hope to complete a reverse takeover under the AIM rules before 30September 2006. The principal terms of the Loan Stock are as follows: 1 Unless previously converted or repaid, the Loan Stock isrepayable 24 months from the date of the Loan Stock instrument under which it iscreated (the "Instrument") or at any time after 31 October 2006 at the Company'soption. 2 In partial consideration for the Loan Stock holderssubscribing for Loan Stock, a premium ("Premium") of £2 for each £1 nominal ofLoan Stock is payable, unless previously converted or paid, 24 months from thedate of the Instrument, or at any time after 31 October 2006 at the Company'soption. 3 Interest is payable from 1 November 2006 on the amount ofthe Loan Stock at the rate of two per cent. over the base rate of the Bank ofScotland plc from time to time. Interest is payable twice yearly. The firstinterest period will run from 1 November 2006 to 31 March 2007. 4 The conversion of Loan Stock ("Conversion") into OrdinaryShares is conditional upon approval by shareholders of resolutions to allotshares and disapply pre-emption rights; and if appropriate, the approval by avote of independent shareholders taken on a poll of any waiver granted by thePanel on Takeovers and Mergers of any obligation under rule 9 of the City Codeon Takeovers and Mergers which may arise from such Conversion (together the "Conversion Event") 5 Immediately prior to the Conversion Event, the Loan Stockis deemed repayable and the Premium is deemed payable. 6 On the Conversion Event, the Loan Stock and the Premiumwhich has not been repaid or paid as the case may be, will be converted intoOrdinary Shares in the capital of the Company at the rate of 100 Ordinary Sharesof the Company for each £1 otherwise due for repayment or payment. 7 So far as it is lawfully able to do so, the Company willnotify the Loan Stock holders at least 10 days in advance of the likelyoccurrence of the Conversion Event. 8 The Loan Stock is transferable in multiples of £10,000. 9 The Company is obliged to repay the Loan Stock and pay thePremium on the occurrence of certain events, including certain insolvencyevents. 10 Decisions relating to the Loan Stock are to be taken by a writtenresolution of the holders of at least two thirds in nominal value of theoutstanding Loan Stock. Applications for the Loan Stock may only be made for a minimum of £1,000 nominaland in multiples of £1,000. Applications for the Loan Stock are to be receivedby the Company at One Great Cumberland Place, London W1H 7AL by 3.00pm on 31July 2006. A copy of the letter despatched to shareholders and the Instrument are availablefor inspection, on request, at Halliwells LLP, 1 Threadneedle Street, LondonEC2R 8AW during normal business hours on any weekdays, Saturdays, Sundays andpublic holidays excluded, for one month from today. For further information, please contact: Barry Gold, Azure Holdings plcTel: 07768 948 928 David Youngman, WH Ireland Limited Tel: 0161 832 2174 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Aug 20203:57 pmRNSHolding(s) in Company
10th Aug 20203:05 pmRNSHolding(s) in Company
7th Aug 20202:20 pmRNSDirector/PDMR Shareholding
5th Aug 20203:14 pmRNSHolding(s) in Company
3rd Aug 20202:49 pmRNSHolding(s) in Company
30th Jul 202011:05 amRNSSecond Price Monitoring Extn
30th Jul 202011:00 amRNSPrice Monitoring Extension
24th Jul 202012:38 pmRNSBroker Option - Fully Subscribed
23rd Jul 20204:41 pmRNSSecond Price Monitoring Extn
23rd Jul 20204:36 pmRNSPrice Monitoring Extension
23rd Jul 20203:02 pmRNSFundraise
23rd Jul 20201:00 pmRNSResult of AGM
23rd Jul 20207:00 amRNSAGM Statement
17th Jul 20209:14 amRNSAGM Arrangements
6th Jul 20207:00 amRNSCorporate Update
1st Jul 20207:00 amRNSNotice of AGM
1st Jul 20207:00 amRNSFinal Results
29th Jun 202011:44 amRNSAppointment of Director
24th Jun 20201:24 pmRNSHolding(s) in Company
23rd Jun 20205:26 pmRNSHolding(s) in Company
22nd Jun 20202:06 pmRNSSecond Price Monitoring Extn
22nd Jun 20202:00 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSCorporate Update
11th Jun 20207:00 amRNSNew shareholder communication process
8th Jun 202011:08 amRNSCorrection Directorate Change & Audited accounts
8th Jun 20207:00 amRNSDirectorate Change & Audited accounts extension
2nd Jun 20209:56 amRNSHolding(s) in Company
2nd Jun 20209:05 amRNSSecond Price Monitoring Extn
2nd Jun 20209:00 amRNSPrice Monitoring Extension
2nd Jun 20207:41 amRNSCollaboration Agreement Signed
29th May 20207:00 amRNSPatent Assignment
27th May 20201:34 pmRNSHolding(s) in Company
27th May 20209:57 amRNSProposed Board Change
27th May 20208:54 amRNSHolding(s) in Company
27th May 20207:00 amRNSHolding(s) in Company
22nd May 202012:04 pmRNSResult of General Meeting
19th May 20202:00 pmRNSGroup Projects Summary & Board Expansion Plans
7th May 20202:05 pmRNSSecond Price Monitoring Extn
7th May 20202:01 pmRNSPrice Monitoring Extension
7th May 20207:00 amRNSAppointment of Director
6th May 20204:23 pmRNSPosting of Circular and Notice of General Meeting
6th May 20209:05 amRNSHolding(s) in Company
4th May 20203:00 pmRNSBroker Option - Fully Subscribed
4th May 20208:27 amRNSHolding(s) in Company
4th May 20208:24 amRNSHolding(s) in Company
4th May 20207:00 amRNSConditional Fundraise of £1.2 million
1st May 20201:34 pmRNSShare Price Movement
1st May 20209:21 amRNSHolding(s) in Company
1st May 20208:16 amRNSMaterial Transfer Agreement
1st May 20207:00 amRNSProposed appointment of Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.